Maureen Cronin

Active 1986–2022

37
Papers
19,192
Citations
35
h-index
37
i10-index

Citations

Citations per year for Maureen Cronin1987: 4 citations1988: 5 citations1989: 6 citations1990: 2 citations1991: 4 citations1992: 1 citations1993: 3 citations1994: 3 citations1995: 3 citations1996: 4 citations1997: 6 citations1998: 13 citations1999: 13 citations2000: 12 citations2001: 10 citations2002: 15 citations2003: 12 citations2004: 24 citations2005: 71 citations2006: 104 citations2007: 146 citations2008: 174 citations2009: 197 citations2010: 200 citations2011: 186 citations2012: 182 citations2013: 286 citations2014: 237 citations2015: 280 citations2016: 279 citations2017: 220 citations2018: 251 citations2019: 640 citations2020: 582 citations2021: 481 citations2022: 391 citations2023: 275 citations2024: 357 citations2025: 133 citations2026: 15 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,932 citing papers, 34.1% of this breakdownUnited Kingdom: 645 citing papers, 7.5% of this breakdownChina: 480 citing papers, 5.6% of this breakdownItaly: 429 citing papers, 5% of this breakdownGermany: 393 citing papers, 4.6% of this breakdownCanada: 335 citing papers, 3.9% of this breakdownFrance: 330 citing papers, 3.8% of this breakdownNetherlands: 284 citing papers, 3.3% of this breakdownAustralia: 229 citing papers, 2.7% of this breakdownSwitzerland: 216 citing papers, 2.5% of this breakdownSpain: 215 citing papers, 2.5% of this breakdownJapan: 207 citing papers, 2.4% of this breakdown
0%34.1%Other 22.1%

Fields

  • Biochemistry, Genetics and Molecular Biology49.1%
  • Medicine41.9%
  • Computer Science2.3%
  • Pharmacology, Toxicology and Pharmaceutics1.6%
  • Immunology and Microbiology1.3%
  • Health Professions0.9%
  • Other2.9%

Topics

  • Cancer Genomics and Diagnostics7.5%
  • Breast Cancer Treatment Studies7.2%
  • Lung Cancer Treatments and Mutations4.2%
  • HER2/EGFR in Cancer Research3.5%
  • Gene expression and cancer classification2.8%
  • Cancer Cells and Metastasis2.2%
  • Other72.6%

Coauthors

All papers

Open in search
  1. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cyrus V. Hedvat, Michael F. Berger, Lajos Pusztai, Matthias Lechner, Chris Boshoff, Mirna Jarosz, Christine Vietz, Alex Parker, Vincent A. Miller, Jeffrey S. Ross, John A. Curran, Maureen Cronin, Philip J. Stephens, Doron Lipson, Roman Yelensky - Nature Biotechnology 2013 cited by 2,191

  2. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 6,358

  3. Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent A. Miller - Clinical Cancer Research 2014 cited by 662

  4. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2006 cited by 2,577

  5. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 645

  6. Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 477

  7. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pasi A. Jänne, Philip J. Stephens - Nature Medicine 2012 cited by 869

  8. Big data from electronic health records for early and late translational cardiovascular research: challenges and potential

    Authors: , , , , , , , , , , , , - European Heart Journal 2017 cited by 216

  9. CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lothar Roessig, Carl Steinbeisser, Mats Sundgren, Benoît Tyl, Ghislaine J. M. W. van Thiel, Kees van Bochove, Panos Vardas, Tiago Villanueva, Marilena Vrana, Wim Weber, Franz Weidinger, Stephan Windecker, Angela Wood, Diederick E. Grobbee - The Lancet Digital Health 2022 cited by 70

  10. Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity

    Authors: , , , , , , , , , , , , , - European Urology 2012 cited by 457

  11. The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review

    Authors: , , , , , , , , , , , , , - The Lancet Digital Health 2022 cited by 76

  12. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lothar Roessig, Carl Steinbeisser, Mats Sundgren, Benoît Tyl, Ghislaine J. M. W. van Thiel, Kees van Bochove, Panos Vardas, Tiago Villanueva, Marilena Vrana, Wim Weber, Franz Weidinger, Stephan Windecker, Angela Wood, Diederick E. Grobbee, Xavier Kurz, John Concato, Robert Kazmierski, Jose P. Morales, Ileana L. Piña, Wim Goettsch, Adrian Jonas, Niklas Hedberg, Filippo Crea, Thomas F. Lüscher, Wim Weber, Tiago Villanueva, Stuart Spencer, Rupa Sarkar, Martin Fredriksson, Mats Sundgren, Andrea Derix, Gunnar Brobert, Lothar Roessig, Benoît Tyl, Kees van Bochove, Maureen Cronin, Colm Carroll, Ceri Thompson, Birgit Beger, Susanne Løgstrup, Marilena Vrana, Paul McGreavy, Barbara Casadei, Stephan Achenbach, Valentina Tursini, Panos Vardas, Dan Atar, Colin Baigent, Chris P Gale, Donna Fitzsimons, Stephan Windecker, Stefan D. Anker, Martín Cowie, Amitava Banerjee, Harry Hemingway, R Tom Lumbers, Spiros Denaxas, Folkert W. Asselbergs, Rick Grobbee, Ghislaine J. M. W. van Thiel, Dipak Kotecha, George V Gkoutos, Angela Wood, Martin Ingvar, Carl Steinbeisser, Anastasia Petrova, Cinzia Ceccarelli, Katija Baljevic, Polyxeni Vairami, Jennifer Taylor - European Heart Journal 2022 cited by 36

  13. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lothar Roessig, Carl Steinbeisser, Mats Sundgren, Benoît Tyl, Ghislaine J. M. W. van Thiel, Kees van Bochove, Panos Vardas, Tiago Villanueva, Marilena Vrana, Wim Weber, Franz Weidinger, Stephan Windecker, Angela Wood, Diederick E. Grobbee - BMJ 2022 cited by 47

  14. Tissue Handling and Specimen Preparation in Surgical Pathology: Issues Concerning the Recovery of Nucleic Acids From Formalin-Fixed, Paraffin-Embedded Tissue

    Authors: , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2008 cited by 279

  15. Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 620

  16. Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor–Positive Breast Cancer

    Authors: , , , , , , , , , - Clinical Chemistry 2007 cited by 345

  17. Generalizability of randomized controlled trials in heart failure with reduced ejection fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal - Quality of Care and Clinical Outcomes 2021 cited by 36

  18. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors

    Authors: , , , , , , , , , , , , , , , , , , , - Genome Medicine 2013 cited by 217

  19. Pharmacogenomics: The promise of personalized medicine

    Authors: , , - AAPS PharmSci 2000 cited by 267

  20. Tumor Gene Expression and Prognosis in Breast Cancer Patients with 10 or More Positive Lymph Nodes

    Authors: , , , , , , , , , - Clinical Cancer Research 2005 cited by 230

  21. Investigation of the use of a sensor bracelet for the presymptomatic detection of changes in physiological parameters related to COVID-19: an interim analysis of a prospective cohort study (COVI-GAPP)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - BMJ Open 2022 cited by 34

  22. Extension of a Pilot Study: Impact From the Cytochrome P450 2D6 Polymorphism on Outcome and Costs Associated With Severe Mental Illness

    Authors: , , , , , , , , , , , - Journal of Clinical Psychopharmacology 2000 cited by 228

  23. Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2012 cited by 105

  24. Measurement of Gene Expression in Archival Paraffin-Embedded Tissues

    Authors: , , , , , , , - American Journal Of Pathology 2004 cited by 566